News About: Pharm. Industry
Two different extreme ways in R&D of listed pharmaceutical companies, more than 20% of Hanmi against 0.1% of Daihan Pharm
While some pharmaceutical companies have invested more than 20% of sales in R&D (research and development), there are also pharmaceutical companies spending so less in R&D that the expenses cannot even be called as R&...
The more partnerships domestic pharmaceutical companies make with multinational companies, the stricter CP policies gets
Is it really inevitable for top domestic pharmaceutical companies promoting introduced products of multinational pharmaceutical companies to have tight CP (Compliance Program) policies?
It is criticized in the pharma...
The salary king as a directive in the pharmaceutical industry is CEO Jung-seok Kang of Dong-A Socio Holdings
CEO Jung-seok Kang of Dong-A Socio Holdings became the salary king among other executives in listed pharmaceutical companies.
According to the Financial Supervisory Service on the last 31st, CEO Jung-seok Kang of Don...
The Ministry of Food and Drug Safety and pharmaceutical companies formed the export promotion conference
In order to lessen differences of opinions and share information in the pharmaceutical export field, the Ministry of Food and Drug Safety and pharmaceutical companies’ directors in charge of exportation will form a co...
Pharmaceutical companies will tighten supervisions towards pharmaceutical distribution companies’ aberrations
It seems that pharmaceutical companies will strengthen the management towards pharmaceutical distribution companies.
Although the pressure has mainly been focused on loan controls due to management crisis of wholesal...
“Will pharmacies will cooperate with the online market, instead of competiting?”
As competition gets fierce against online channels in the cosmetic and health functional food industries, new recognition has been raised that pharmacies should newly settle down in the field. In the current circumsta...
‘Samsung’ emphasizing the bio industry announced fluctuation in the pharmaceutical market
As Samsung indicated the bio industry as its target industry, fluctuation is expected in the pharmaceutical industry as well.
Vice president Jae-yong Lee of Samsung Electronics unveiled an active will to expand its b...
MSD founded a special antibody business unit just for ‘Keytruda’
MSG has a high hope towards its antibody ‘Keytruda’.
Merck has recently spoken that it will launch Oncology Business Units at its branches all over the world, including the Korean branch.
For the reason, Joseph Eid ...
The Dong-A ST’s has been approved to sell Sivextro in Europe
Dong-A ST (CEO Chan-il Phark) announced on the 27th that the superbacteria-targeting antibiotic ‘Sivextro’ acquired a selling approval from the European Commission on the 23rd in Europe.
Under the approval, Sivextro ...
Due to trouble in sales activities, sales promotion expenses of listed pharmaceutical companies have decreased
As pharmaceutical companies are having trouble on sales activities due to intension of the rebate restriction, it seems that sales promotion expenses tend to decrease as well.
According to the YakupDotCom’s analysis ...
